SCHW
53
-11
LYB
25
-14
IPG
49
2
A
39
-2
AIV
65
-6
LEN
45
3
DIS
72
-5
CSX
44
-2
XRX
52
3
NDAQ
50
-6
FOX
68
-2
MAS
52
-2
INTU
59
-3
AAPL
64
11
EMC
71
3
SBUX
32
-9
DG
14
-3
EW
53
-2
PDCO
74
-3
CMG
69
-4
SCHW
53
-11
LYB
25
-14
IPG
49
2
A
39
-2
AIV
65
-6
LEN
45
3
DIS
72
-5
CSX
44
-2
XRX
52
3
NDAQ
50
-6
FOX
68
-2
MAS
52
-2
INTU
59
-3
AAPL
64
11
EMC
71
3
SBUX
32
-9
DG
14
-3
EW
53
-2
PDCO
74
-3
CMG
69
-4
Financhill
Back

Telix Pharmaceuticals 10K Form

Buy
81

TLPPF
Telix Pharmaceuticals

Last Price:
16.00
Seasonality Move:
-12.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TLPPF News And Ratings

See the #1 stock for the next 7 days that we like better than TLPPF

TLPPF Financial Statistics

Sales & Book Value

Annual Sales: $329.72M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.81
Price / Book: 19.83

Profitability

EPS (TTM): 0.09750
Net Income (TTM): $32.27M
Gross Margin: $204.81M
Return on Equity: 22.95%
Return on Assets: 9.93%

Telix Pharmaceuticals Earnings Forecast

Key Telix Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for TLPPF is 62.12%.
  • The Selling, General & Administrative Expenses for TLPPF have been equal to 26.95% of Gross Profit Margin.
  • The Research & Development expenses have been 25.94% of Revenue.
  • The Interest Expense is 252.08% of Operating Income.
  • The Net Earning history of TLPPF is 1.05% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Telix Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: TLPPF
Website: telixpharma.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 0.99
Quick Ratio: 0.81

Price-to-Earnings

Trailing P/E Ratio: 1497.01
Forward P/E Ratio: 0

TLPPF Technical Analysis vs Fundamental Analysis

Buy
81
Telix Pharmaceuticals (TLPPF) is a Buy

Is Telix Pharmaceuticals a Buy or a Sell?